+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

Circulation 111(5): 570-575

Background - Lipoprotein- associated phospholipase A2 ( Lp- PLA2) has been proposed as an inflammatory marker of cardiovascular disease. In the present study, we investigated whether Lp- PLA2 is an independent predictor of coronary heart disease and ischemic stroke. Methods and Results - The Rotterdam Study is a population- based follow- up study in 7983 subjects gtoreq 55 years of age.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012267276

Download citation: RISBibTeXText

PMID: 15699277

DOI: 10.1161/01.cir.0000154553.12214.cd

Related references

Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry 471: 38-45, 2017

Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study. European Heart Journal 27(19): 2346-2352, 2006

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology 51(17): 1632-1641, 2008

Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women. American Heart Journal 161(3): 516-522, 2011

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. Journal of the American Heart Association 5(6):, 2016

Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 41(3): 426-430, 2010

PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry. Circulation 121(21): 2284-2293, 2010

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113(5): 657-663, 2006

Dairy products and the risk of stroke and coronary heart disease: the Rotterdam Study. European Journal of Nutrition 54(6): 981-990, 2015

A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis 223(2): 421-426, 2012

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 375(9725): 1536-1544, 2010

Lipoprotein-associated phospholipase-A 2 activity and its diagnostic potential in patients with acute coronary syndrome and acute ischemic stroke. Turkish Journal of Emergency Medicine 17(2): 56-60, 2017

High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke 28(1): 83-87, 1997

Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model. Bmc Medicine 10: 158, 2012

Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes. Diabetes 59(5): 1239-1243, 2010